Publication:
The impact of bevacizumab usage on patients who were curative resected for liver-confined metastases from colorectal cancer

Simple item page
dc.contributor.authorDANE, FAYSAL
dc.contributor.authorsTuran, N.; Koca, D.; Dane, F.; Ozdemir, N.; Ustaalioglu, B. B. Oven; Oztop, I.; Ulas, A.; Berk, V.; Kucukoner, M.; Balakan, O.; Ozturk, M. A.; Benekli, M.; Gumus, M.; Yilmaz, U.; Ozkan, S.; Buyukberber, S.
dc.date.accessioned2022-03-10T17:50:52Z
dc.date.accessioned2026-01-11T06:28:47Z
dc.date.available2022-03-10T17:50:52Z
dc.date.issued2011
dc.identifier.doi10.1200/jco.2011.29.15_suppl.e14120
dc.identifier.eissn1527-7755
dc.identifier.issn0732-183X
dc.identifier.urihttps://hdl.handle.net/11424/221408
dc.identifier.wosWOS:000208880303517
dc.language.isoeng
dc.publisherAMER SOC CLINICAL ONCOLOGY
dc.relation.ispartofJOURNAL OF CLINICAL ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleThe impact of bevacizumab usage on patients who were curative resected for liver-confined metastases from colorectal cancer
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.issue15
oaire.citation.titleJOURNAL OF CLINICAL ONCOLOGY
oaire.citation.volume29

Files

Collections

Araştırma Çıktıları